Detection of semenogelin 1 amyloidosis through immunohistochemical staining with novel antiserum developed based on mass spectrometric peptide mapping analysis

Amyloid. 2022 Dec;29(4):278-280. doi: 10.1080/13506129.2022.2101920. Epub 2022 Jul 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amyloidosis* / diagnosis
  • Humans
  • Mass Spectrometry
  • Peptide Mapping
  • Staining and Labeling